Kiora Pharmaceuticals Inc SC 13D and SC 13D/A reports

Location
332 Encinitas Boulevard, Suite 102, Encinitas, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/21/2024, 01:25 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report Aug 3, 2021
SC 13D/A Report Jan 12, 2021
SC 13D/A Report Jan 15, 2020
SC 13D/A Report Jan 10, 2020
SC 13D/A Report Oct 18, 2019
SC 13D/A Report Oct 2, 2019
SC 13D/A Report Apr 4, 2019
SC 13D/A Report Aug 10, 2018
SC 13D/A Report May 17, 2018
SC 13D Report Apr 23, 2018
SC 13D/A Report SC 13D/A Jan 17, 2018
SC 13D/A Report AMENDMENT NO. 3 Jan 2, 2018
SC 13D/A Report SCHEDULE 13D/A Dec 19, 2017
SC 13D/A Report SC 13D/A Jun 16, 2017
SC 13D/A Report SC 13D/A Jun 16, 2017
SC 13D Report SC 13D Mar 4, 2015
SC 13D Report SC 13D Mar 3, 2015
SC 13D Report SC 13D Mar 2, 2015